rs61753391

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001256864.2(DNAJC6):​c.678G>A​(p.Ala226Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0231 in 1,516,340 control chromosomes in the GnomAD database, including 483 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 30 hom., cov: 32)
Exomes 𝑓: 0.024 ( 453 hom. )

Consequence

DNAJC6
NM_001256864.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.199

Publications

2 publications found
Variant links:
Genes affected
DNAJC6 (HGNC:15469): (DnaJ heat shock protein family (Hsp40) member C6) DNAJC6 belongs to the evolutionarily conserved DNAJ/HSP40 family of proteins, which regulate molecular chaperone activity by stimulating ATPase activity. DNAJ proteins may have up to 3 distinct domains: a conserved 70-amino acid J domain, usually at the N terminus, a glycine/phenylalanine (G/F)-rich region, and a cysteine-rich domain containing 4 motifs resembling a zinc finger domain (Ohtsuka and Hata, 2000 [PubMed 11147971]).[supplied by OMIM, Mar 2008]
DNAJC6 Gene-Disease associations (from GenCC):
  • juvenile onset Parkinson disease 19A
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • atypical juvenile parkinsonism
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • young-onset Parkinson disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 1-65384204-G-A is Benign according to our data. Variant chr1-65384204-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 474681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.199 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.018 (2733/152158) while in subpopulation NFE AF = 0.027 (1837/67996). AF 95% confidence interval is 0.026. There are 30 homozygotes in GnomAd4. There are 1314 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 30 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAJC6NM_001256864.2 linkc.678G>A p.Ala226Ala synonymous_variant Exon 6 of 19 ENST00000371069.5 NP_001243793.1 O75061-2
DNAJC6NM_014787.4 linkc.507G>A p.Ala169Ala synonymous_variant Exon 6 of 19 NP_055602.1 O75061-1
DNAJC6NM_001256865.2 linkc.468G>A p.Ala156Ala synonymous_variant Exon 7 of 20 NP_001243794.1 O75061-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAJC6ENST00000371069.5 linkc.678G>A p.Ala226Ala synonymous_variant Exon 6 of 19 1 NM_001256864.2 ENSP00000360108.4 O75061-2

Frequencies

GnomAD3 genomes
AF:
0.0180
AC:
2736
AN:
152040
Hom.:
30
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00444
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.0190
Gnomad ASJ
AF:
0.0176
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00499
Gnomad FIN
AF:
0.0246
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0270
Gnomad OTH
AF:
0.0230
GnomAD2 exomes
AF:
0.0203
AC:
3818
AN:
188090
AF XY:
0.0206
show subpopulations
Gnomad AFR exome
AF:
0.00424
Gnomad AMR exome
AF:
0.0117
Gnomad ASJ exome
AF:
0.0156
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0220
Gnomad NFE exome
AF:
0.0294
Gnomad OTH exome
AF:
0.0299
GnomAD4 exome
AF:
0.0236
AC:
32240
AN:
1364182
Hom.:
453
Cov.:
30
AF XY:
0.0231
AC XY:
15589
AN XY:
675412
show subpopulations
African (AFR)
AF:
0.00454
AC:
131
AN:
28824
American (AMR)
AF:
0.0137
AC:
410
AN:
29924
Ashkenazi Jewish (ASJ)
AF:
0.0183
AC:
423
AN:
23168
East Asian (EAS)
AF:
0.0000299
AC:
1
AN:
33450
South Asian (SAS)
AF:
0.00670
AC:
469
AN:
69982
European-Finnish (FIN)
AF:
0.0235
AC:
1215
AN:
51612
Middle Eastern (MID)
AF:
0.0398
AC:
217
AN:
5450
European-Non Finnish (NFE)
AF:
0.0263
AC:
28072
AN:
1065668
Other (OTH)
AF:
0.0232
AC:
1302
AN:
56104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
1570
3140
4711
6281
7851
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1076
2152
3228
4304
5380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0180
AC:
2733
AN:
152158
Hom.:
30
Cov.:
32
AF XY:
0.0177
AC XY:
1314
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.00446
AC:
185
AN:
41526
American (AMR)
AF:
0.0190
AC:
290
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0176
AC:
61
AN:
3468
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5158
South Asian (SAS)
AF:
0.00457
AC:
22
AN:
4810
European-Finnish (FIN)
AF:
0.0246
AC:
261
AN:
10598
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0270
AC:
1837
AN:
67996
Other (OTH)
AF:
0.0227
AC:
48
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
141
282
422
563
704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0233
Hom.:
102
Bravo
AF:
0.0174
Asia WGS
AF:
0.00375
AC:
13
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 06, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Juvenile onset Parkinson disease 19A Benign:2
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
7.8
DANN
Benign
0.72
PhyloP100
-0.20
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61753391; hg19: chr1-65849887; COSMIC: COSV104554443; COSMIC: COSV104554443; API